Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer
NCT03251612
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer Metastatic
Interventions
DRUG:
Based on sensitivity analysis
Sponsor
Vejle Hospital